Researching medical device manufacturer subsidiaries requires crossing two evidentiary systems: securities disclosures that name corporate ownership and FDA records that identify regulated establishments. The workflow begins with the parent company's annual report or Form 10-K, specifically Exhibit 21, which lists subsidiaries and their jurisdictions. From there, FDA's Registration & Listing database and Devices@FDA connect an establishment to cleared or approved devices. Device Master Files add a third layer when a subsidiary supplies components or procedures without submitting directly to FDA. Each source answers a different question, and none alone provides a complete ownership map. The practical task is sequencing these documents against a precise research objective and recording what remains unconfirmed at each step.
Start With the Corporate Disclosure Layer
The Form 10-K provides the first documentary anchor for subsidiary identification. In Globus Medical's fiscal 2025 annual report, filed February 24, 2026, the company describes the NuVasive merger completed September 1, 2023, in which Zebra Merger Sub Inc., a wholly owned subsidiary, merged into NuVasive, with NuVasive surviving as a wholly owned subsidiary [2]. This language establishes a subsidiary's origin and current status through a single named transaction. The report's subsidiary listing then shows named entities in Germany, Italy, Japan, Australia, and the Netherlands, among others [2].
For broader ownership mapping, Exhibit 21 accompanying Form 10-K is the more systematic document. Boston Scientific's Exhibit 21, dated as of January 31, 2025, states that the company wholly owns or holds a majority interest in all listed entities and then enumerates subsidiaries by jurisdiction, including Boston Scientific Japan K.K., Boston Scientific Medical Device Limited in Ireland, and BTG International Limited in England [3]. The geographic spread and legal-form suffixes—GmbH, S.r.l., Pty. Ltd.—indicate where holding structures terminate at operating entities. A researcher should treat the Exhibit 21 date as the ownership snapshot date, because mergers and dissolutions after that date will not appear.
Connect Subsidiaries to FDA Registration Records
FDA registration records answer which establishment performs device activities, not which corporation owns it. Under 21 CFR Part 807, an owner or operator of an establishment must register its name, places of business, and all establishments, and list devices, whether or not output enters interstate commerce [1]. The Registration & Listing database at FDA contains establishments engaged in manufacture, preparation, compounding, assembly, or processing of devices intended for human use and commercial distribution, for both domestic and foreign manufacturers [5]. A researcher can search this database to find the operator name on file and the listed activities.
The critical distinction is between internal transfer and commercial distribution. The regulation excludes from commercial distribution any internal or interplant transfer of a device between establishments within the same parent, subsidiary, and/or affiliate company [1]. This means a physical movement between two corporate affiliates may not generate a separate registration event tied to that specific transfer. Registration and listing also do not denote clearance or approval of an establishment or its products [7]. When a subsidiary appears in registration data, the researcher should not infer that all its devices are lawfully marketed or that ownership is current, only that the establishment performed a listed activity as reported.
How to Document One Subsidiary in One Sitting
Open the parent's latest annual report on EDGAR or the investor relations site and locate Exhibit 21 if the filing includes one. Note the as-of date and conduct a page search for the country or brand in question. Boston Scientific's January 31, 2025 exhibit, for example, lists American Medical Systems Europe B.V. in the Netherlands and BTG Limited in England by jurisdiction [3]. Record the exact legal name and corporate suffix as written.
Next, query FDA's Registration & Listing database by establishment or operator name to see whether the subsidiary appears as a registered establishment and what activities it lists [5]. For a device-level check, search Devices@FDA for the product name and compare the manufacturer field with the subsidiary name from the exhibit [5]. If the product references a master file, note the MAF number and any public holder identification, without assuming the MAF's substantive content is accessible [4]. End by recording the as-of date for each database and the gap between it and the corporate filing date.
Trace Contract Manufacturing and Supplier Relationships Through Master Files
Device Master Files become relevant when a subsidiary supplies components, materials, or services to another manufacturer rather than submitting its own premarket application. FDA's guidance explains that a PMA or IDE applicant often uses another party's product or facility in manufacture, and for a sound scientific evaluation, FDA may need data that the third party regards as trade secret or confidential [4]. The MAF mechanism lets the supplier hold that information while authorizing FDA to review it in support of the client's submission. MAFs are typically accepted from organizations that have not submitted or will not directly submit the information in a PMA, IDE, 510(k), or other device submission [4].
An MAF holder that performs manufacturing or processing under 21 CFR 820 must address all applicable good manufacturing practice requirements for its operation [4]. This linkage means an MAF can surface a subsidiary operating as a contract manufacturer whose identity otherwise remains hidden in the client's public submission. To investigate this relationship, a researcher checks whether a device submission references an MAF by number and then seeks the MAF's public cover information, understanding that trade secret content itself is not disclosed under FOI unless already in the public domain [4]. The subsidiary's role as MAF holder may be the only public trace of a confidential supply arrangement.
Building and Testing a Subsidiary Profile
A suggested workflow for a hypothetical evaluation starts with a target device family and ends with a documented ownership record. Suppose a researcher is assessing a spinal implant marketed under a recently acquired brand. Step one is the parent's latest Form 10-K or Exhibit 21 to identify the acquiring subsidiary and jurisdiction [2][3]. Step two searches Devices@FDA, which catalogs cleared and approved device information including manufacturer, approval date, and user instructions, drawing from 510(k) and PMA records [5]. Step three queries the Registration & Listing database to see which listed establishment performs manufacture or processing for that device [5]. Step four checks for MAF references in the submission files, if accessible, to identify component or sterilization suppliers [4].
Each step produces evidence with different limitations. A 10-K subsidiary list may precede a subsequent corporate restructuring by months. Registration records reflect establishment activities, not corporate control, and internal transfers between affiliates are excluded from the relevant distribution definition [1]. Devices@FDA shows the manufacturer named in a clearance or approval, but a contract manufacturer may perform substantial work without appearing in the summary record [5]. An MAF reference may identify a supplier only by file number, with holder identity and content subject to confidentiality [4]. When the workflow concludes, the researcher should record each subsidiary's legal name, jurisdiction, source document, and as-of date separately, because no single document supplies all four fields.
Recognizing What the Records Cannot Establish
Several conclusions exceed what the documents support. SEC Exhibit 21 confirms ownership structure as of a stated date but does not state whether a listed foreign entity is an active manufacturer, a holding vehicle, or a dormant legal shell [3]. FDA registration confirms that an establishment declared certain device activities, but registration itself carries no approval meaning [7]. Devices@FDA records may attribute a device to a manufacturer entity that is not the entity doing daily production, because the database summarizes submission information rather than manufacturing operations [5].
Across sources, no single record ties corporate control to regulatory compliance for a particular device family. A subsidiary may appear in a 10-K and in registration data, yet the connection between the two—who directed the manufacturing, who held the design controls, who is responsible for medical device reporting—may require the full submission file or inspection history, which public databases do not always supply [1][5]. When a research question asks about operational responsibility, the correct answer may be that the available sources show ownership and declared establishment activities but not the internal allocation of regulatory duties.
Sources & references
- eCFR :: 21 CFR Part 807 -- Establishment Registration and Device Listing for Manufacturers and Initial Importers of Devices · www.ecfr.gov
- Form 10-K for Globus Medical INC filed 02/24/2026 · www.investors.globusmedical.com
- Exhibit21 Listofsubsidiari · www.sec.gov
- Device Master Files | FDA · www.fda.gov
- Medical Device Databases | FDA · www.fda.gov
- Overview of Device Regulation | FDA · fda.gov
- How to Study and Market Your Device | FDA · fda.gov
- Subsidiaries - Boston Scientific · www.bostonscientific.com